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The MarR family of transcriptional regulators is an important group of 
prokaryotic DNA binding proteins.  As the family name implies, multiple antibiotic 
resistance, members of the MarR family often regulate the expression of resistance genes 
to multiple antibiotics, organic solvents, household disinfectants, detergents, and 
oxidative stress agents.  Most MarR members act as transcriptional repressors and exist 
as homodimers in both free and DNA-bound states.  DNA-binding is mediated via a 
winged-helix fold and is often relieved by anionic lipophilic ligands.  Deinococcus 
radiodurans R1 was found to encode a 181 residue MarR homolog designated HucR 
(hypothetical uricase regulator).  Biochemical evidence has shown that HucR negatively 
regulates expression of uricase and this repression is attenuated by the binding of uric 
acid, which is the natural substrate for uricase.  In this study we present the crystal 
structure of HucR determined to 2.3 Å in the absence of ligand.  In addition, a second 
crystal form of HucR was determined to 2.9 Å in which three dimers were observed in 
the asymmetric unit. Unlike the crystal structure of the MarR homolog, MexR, HucR 
does not display large conformational heterogeneity between dimers.  Furthermore, 
superpositioning of the HucR dimer with the crystal structure of the OhrR dimer 
complexed with DNA suggests that HucR is in a “DNA ready” confirmation in which the 
lobes of the DNA binding domains are in a position compatible with DNA binding, with 
the exception of  minor localized conformational changes needed at the amino termini of 
the recognition helices.  This is in contrast to what is observed when comparing the 
crystal structures of the DNA-bound and unbound OhrR, in which there is a significant 
 viii
displacement of the DNA binding domains as a result of conformational changes that 
originate at the dimerization interface.  The crystal structure of HucR in the absence of 
either ligand or DNA suggests that HucR is likely to be fixed in a “DNA ready” 
conformation.  Thus, the crystal structure of HucR has given new insight into the MarR 
family of transcriptional regulators, proving that although these family members share 









REVIEW OF LITERATURE 
 
 
Transcriptional Regulators and the Helix-turn-helix DNA Binding Motif 
 
 
Transcription is a very intricate cellular process whether it occurs in a prokaryotic 
or eukaryotic cell.  Eukaryotic transcription is much more complex and far less 
understood compared to that of transcription in prokaryotes.  Eukaryotes often require a 
multitude of trans-acting factors in addition to RNA polymerase in order to achieve 
successful transcript production.  In either case, transcriptional regulators (i.e. 
transcription factors or trans-acting proteins) are DNA binding proteins that play a vital 
role in modulating gene expression within a cell.  In fact, gene expression is primarily 
controlled at the level of transcription.  Transcriptional regulators modulate gene 
expression by either being activators that up-regulate certain genes or repressors which 
down-regulate (i.e. repress) gene expression, or in some cases, they can do both.  
Interestingly, E. coli encodes for a higher proportion of transcriptional repressors than 
activators with 36% being repressors, 30% being activators, and 20% with dual functions 
(1).  Moreover, transcription factors can be classified as either local or global regulators 
depending on the range of genes that they regulate. 
 Transcriptional regulators have been placed into one of several groups primarily 
based on the structure of their DNA binding motifs. Some of these groups include the 
helix-turn-helix (HTH), zinc finger, leucine zipper, helix-loop-helix (HLH), basic 
region/leucine zipper (b/zip), basic region/helix-loop-helix/leucine zipper (b/HLH/zip), 
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homeodomain, β-sheet, and β-ribbon/hairpin proteins  (2,3).  NMR and x-ray crystal 
structures of prokaryotic transcription factors have revealed three principal DNA binding 
motifs: the HTH, winged helix, and the β-ribbon motif (4).   
 The helix-turn-helix DNA binding motif is the most common DNA binding 
structure in bacterial and archaeal transcription factors (1,4).  The classical HTH DNA 
binding motif was first structurally described in the crystal structures of bacteriophage λ 
Cro protein (5,6) and E. coli catabolite activator protein (CAP) (7,8).  The canonical HTH 
motif consists of two consecutive helices (H2 and H3) that are packed at angles of 120º 
relative to each other and are connected by a tight four residue turn in which a glycine is 
usually found at the second position (Fig 1).  Apparently the HTH motif alone is 
insufficient to undergo independent folding and requires an additional α-helix (H1) to 
render this motif as a compact, globular domain (4), which is often collectively referred 
to as the DNA binding domain that typically ranges in size from 60 to 90 amino acids (9).  
The second α-helix of the HTH motif, H3, is often referred to as the “recognition helix” 
and averages nine residues in length.  The recognition helix, as its name implies, is 
important for making most of the sequence specific contacts with its cognate DNA (10).  
This is typically done by insertion of the recognition helix into the major groove of the 
DNA, thus making critical base pair contacts that result in sequence specific DNA 
binding as illustrated in Fig 1.  In fact, each of the four base pairs at the major groove 
provide a distinctive hydrogen bonding pattern (like a fingerprint) often referred to as 
direct readout, whereas the minor groove does not provide such a distinctive pattern (11). 
Nearly all prokaryotic proteins that bind DNA via the HTH motif function as 




Figure 1. Canonical helix-turn-helix DNA binding motif complexed with DNA.  The 
crystal structure of the classical HTH DNA binding motif from E. coli CAP protein 




palindromic or pseudopalindromic DNA sequence which are also related by 2-fold 
symmetry.  However, there is not an absolute requirement for dimerization amongst all 
HTH DNA binding proteins as demonstrated by the fact that some members of the AraC 
family, including E. coli MarA (12) and Rob (13), bind their cognate DNA as monomers.  
Both MarA and Rob have two HTH motifs per monomer. However, MarA uses both of 
its HTH motifs to make contacts with the major groove, whereas Rob only uses one HTH 
motif for major groove recognition and its other HTH motif contributes only DNA 
backbone contacts.  Thus, it is difficult to speculate on the exact mechanism of protein-




The Winged Helix DNA Binding Motif 
 
 Since the original identification of the HTH DNA binding motif in the Cro and 
CAP proteins from bacteriophage λ and E. coli, respectively, structural studies on a 
variety of gene regulatory proteins have led to the identification of several variations of 
the canonical HTH motif.  In fact, variations in this motif are quite common, with HTH 
variants occurring in both prokaryotic and eukaryotic gene regulatory proteins.  Further 
structural disparity within this superfamily came when the co-crystal structure of the 
DNA binding domain of eukaryotic hepatocyte nuclear factor-3 (HNF-3) complexed with 
its target DNA (14) revealed a significant structural adaptation to the canonical HTH 
DNA binding motif.  This new DNA binding element was called a “winged HTH motif” 
(also referred to as a winged helix motif) and was the basis for a new subclassification of 
the canonical HTH DNA binding proteins.   
The winged helix fold has been identified in eukaryotes, prokaryotes, archaea, and 
viruses.  Interestingly, sequence analysis of the DNA binding domains of archaeal 
proteins show that all archaea encode a large number of proteins that contain a HTH 
motif.  The sequences of these motifs are more closely related to those of prokaryotic 
HTH domains than those of eukaryotes.  Furthermore, the winged helix motif appears to 
be the predominant motif used for DNA binding proteins within the archaeal. (15). 
The winged helix domain (Fig 2) is an adaptation of the canonical HTH motif 
with a compact α/β structure that has the following topology: H1-S1-H2-T-H3-S2-W1-
S3-W2, where “H” denotes an α-helix, “S” denotes a β-strand, “T” denotes a turn, and 
“W” denotes a loop (16).  As the name implies, the most striking feature of this class of 
DNA binding proteins is the presence of a structural element referred to as a “wing” that 
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is actually a β-hairpin that immediately follows the HTH motif with H2 and H3 of the 
winged helix motif corresponding to helices of the canonical HTH motif.  The two wings, 
W1 and W2, flank the recognition helix, H3, similar to the wings of a butterfly (hence the 
name, winged helix motif) (16).  Although W1 is always present in members of the 
winged-helix family of DNA binding proteins, W2 is sometimes absent, as observed in 
the structures of histone H5 (17), E2F, DP2 (18) and MarR (19).  Besides the presence of 
the wing, winged helix proteins often deviate from the canonical HTH motif by the 
length of the turn region that separates H2 and H3.  The turn varies among winged helix 
proteins but is typically longer than that of the 3-4 residues from the canonical HTH fold.  
For example, a 10 residue turn separates H2 and H3 in the crystal structure of OmpR 
(20). As a consequence of the extra residues in the turn, the steric hindrance between H2 
and H3 is reduced, allowing for a greater variation in the angles between the two helices 
(100º to 150º) than that of the canonical HTH (120º) (16,4). 
For canonical winged helix DNA binding proteins, the DNA recognition helix 
(H3) is primarily responsible for mediating most, but not all, of the sequence specific 
contacts.  However, the wings seem to differ in their contributions to either sequence-
specific DNA recognition or nonspecific protein/DNA stabilization via phosphate 
backbone contacts. The NMR structure of MuR from bacteriophage Mu in complex with 
its cognate DNA reveals that it uses its wing to make sequence specific contacts as its 
wing is bound to the minor groove where it makes direct hydrogen bonds to the 
nucleotide bases (22).  Moreover, a comparison of the structures of unbound MuR (23) 
with that of DNA-bound MuR reveals that the wing undergoes a disorder-to-ordered 







Figure 2.  Winged helix DNA binding motif.  The winged helix DNA binding motif of 
MecI from Staphylococcus aureus in complex with a 24 bp dsDNA with a 1 bp overhang 
on either side.  Incorporated within this oligonucleotide is the sequence of the blaZ dyad 
that repressor MecI binds.  The recognition helix, H3, is embedded in the major groove of 

















the co-crystal structure of the RFX1-DNA complex (24) revealed that the wing of RFX1 
(W1) makes the majority of its contacts with its cognate DNA by inserting its wing into 
the major groove.  Furthermore, the recognition helix of RFX1 sits over the minor groove 
where it only contributes a single DNA contact via a lysine sidechain and a cytosine.  
Thus, although the winged-helix HTH proteins share a common structural motif, there is 
significant variation in how this motif interacts with DNA.    
Multidrug Resistance and the MarR Family of Transcriptional Regulators 
 
 Multidrug resistance (MDR) is a growing worldwide health issue, as various 
human pathogens are acquiring the ability to survive ordinarily lethal doses of 
structurally diverse drugs (25).  The MDR phenotype can arise via several resistance 
mechanisms including the action of efflux transporters that actively transport a wide 
variety of structurally and chemically dissimilar compounds out of the cell (26).  The 
crucial role these drug efflux transporter systems play in MDR has been well documented 
in eukaryotes as well as prokaryotes (27).  Multidrug transporters are generally integral 
membrane proteins that are often regulated at the transcriptional level by repressors 
and/or activators.  Multidrug pumps are usually upregulated in response to the presence 
of the natural substrates on which these pumps act, usually as a direct result of the 
regulators themselves binding to the same diverse drugs as the substrates for the pumps 
that they regulate (28,29,30).  Due to the inherent difficulty of crystallizing integral 
membrane proteins, there is no structural data to help explain how these transporters 
recognize such a vast array of structurally diverse compounds.  However, since the 
soluble cytosolic regulatory proteins of these transporters also recognize a similar range 
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of drugs, structural studies with transcription factors complexed with various drugs might 
help elucidate the mechanism by which these pumps recognize and bind multiple drugs.   
Although the focus here is on prokaryotic MDR, it is important to mention that 
the development of MDR in tumor cells is also a serious concern and a major cause of 
failure in anti-tumor chemotherapy (31).  Moreover, MDR in tumor cells is usually the 
result of an upregulation of the expression of a specific group of broad substrate spectrum 
membrane phosphoglycoproteins belonging to the ABC transporter superfamily (31).   
Thus, the phenomena of MDR must be addressed at both the prokaryotic and eukaryotic 
levels: to help combat emerging human pathogenic bacteria and to facilitate a better 
efficiency for tumor cell uptake of anticancer drugs, respectively. 
 The E. coli AcrAB-TolC multidrug efflux system functions as a tripartite complex 
that gives rise to a MDR phenotype which is also referred to as a mar phenotype 
(multiple antibiotic resistance) (32) The mar phenotype includes resistance to structurally 
diverse antibiotics, organic solvents, household disinfectants, and oxidative stresses 
(33,34,35).  The mar phenotype in E. coli is directly associated with the expression of the 
marRAB operon, specifically expression of the activator protein, MarA, that activates 
gene expression of the AcrAB-TolC multidrug efflux pump (35,36,37,38).  However, in 
the absence of the appropriate stimulus, MarR negatively regulates the marRAB operon 
(hence the multi drug efflux system), with repression being alleviated by the presence of 
a variety of mostly phenolic-like compounds, most notably salicylate (39,40). 
 Since the discovery of repressor MarR, several homologs have been identified and 
grouped into a common family, the MarR family of transcriptional regulators, named 
after the prototypical member MarR (Table 1).  Proteins that belong to the MarR family 
 8
often act as environmental sensors by modulating gene expression by a rapid response to 
changes in environmental conditions.  This is frequently achieved by binding to the same 
or oftentimes similar substrates as those for the gene products that they regulate.  For 
example, the MarR homolog, HucR, is responsible for repression of the uricase gene in 
Deinococcus radiodurans. However, in the presence of uric acid which is the substrate 
for uricase, HucR-mediated repression of uricase is alleviated (41).  Furthermore, most 
MarR homologs are repressors of the genes to which they regulate with the exception of 
BadR (42), NhhD (43), and ExpG (44) that play roles in activating gene expression, and 
SlyA that appears to have dual roles as both a repressor and an activator (45).   Members 
of the MarR family mediate DNA binding via a winged helix DNA binding motif.  
Moreover, MarR homologs exist as homodimers in both free and DNA-bound states, with 
DNA binding occurring at either palindromic or pseudopalindromic sequence specific 
sites.  Finally, several members of the MarR family have been shown to respond to 
various anionic lipophilic compounds (usually phenolic-like ligands), usually resulting in 
an attenuation of an ability to bind the cognate DNA sequence. 
Hypothetical uricase regulator (HucR) 
 
The eubacterial family Deinococcaceae contains some of earth’s most radiation-
resistant organisms ever described.  Of the several radiation-resistant species of 
Deinococcus identified to date (72), the most extensively studied to date is Deinococcus 
radiodurans R1, for which the complete genome has been sequenced (73).  D. 
radiodurans is a nonpathogenic, gram positive, non-motile, aerobic mesophile best 
known for its remarkable ability to withstand both acute and chronic exposures to high 
levels of ionizing radiation that often leads to double-strand DNA breaks.  D. 
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radiodurans is also highly resistant to other sources of DNA damage including UV 
radiation, desiccation, and oxidative stress (72).  Moreover, D. radiodurans was found to 
encode orthologs to almost all known genes involved in stress responses in bacteria 
including pH, desiccation, temperature, phage, starvation, toxin, antibiotic, and oxidative 
stresses (72,73).   
A gene designated hucR (hypothetical uricase regulator) encoding for a 181 
amino acid protein from D. radiodurans was previously identified and characterized and 
is believed to play a critical role in the cellular response to oxidative stress (41,63). HucR 
shares 29% amino acid sequence identity with prototypical member MarR, thus placing 
HucR in the MarR family of transcriptional regulators.  
The biochemical characterization of HucR revealed that HucR is a transcriptional 
regulatory protein that binds as a homodimer to a single site located within its own 
promoter/operator region (hucO). The HucR binding site within hucO contains a 
pseudopalindromic sequence of 8-bp half sites separated by 2 bp, thus each HucR subunit 
of the dimer binds the same face of the DNA (41).  Furthermore, hucO is also located 
within the promoter region of a separate gene encoding for uricase that is oriented in the 
opposite direction relative to hucR.  Thus, this partial overlapping of promoter regions in 
which the transcriptional start site of each gene is located within the Pribnow box of the 
other provides for a genetically favorable mechanism for the simultaneous co-repression 
of both HucR and uricase. The biological substrate for uricase is uric acid, which is 
converted to allantoin during purine catabolism (Fig. 3) (74).  Interestingly, in vitro 
studies have shown that uric acid appears to be the natural ligand for HucR as it binds 
HucR with an apparent Kd of 5.9 µM. A concomitant antagonistic effect on HucR-DNA 
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binding   is   observed  upon  HucR-uric  acid  binding.    In  fact,  HucR-DNA  complex 
formation is reduced by 50% at uric acid concentrations of 260 µM.  Furthermore, in vivo 
studies have shown that when D. radiodurans was grown in the presence of excess uric 
acid, elevated levels of hucR and uricase transcripts were seen as well as increased 
uricase activity (41).  Taken together, these data strongly support the identification of a 
novel regulatory mechanism for maintaining uric acid homeostasis in D. radiodurans in 
which HucR-mediated repression of uricase is relieved directly by uric acid. 
 
 





Structural Analysis of the MarR Family 
 
 Currently there are four structures of members of the MarR family of 
transcriptional regulators including: MarR (19), MexR (68), SlyA-like protein (65), and 
OhrR (54).  Although this family shares very little amino acid sequence identity, thus far, 
they appear to adopt very similar folds.  Each structure has contributed its own unique 
information about this family of proteins while emphasizing similarities within the 




Table 1.  Summary of the MarR family of transcriptional regulators. 









Repressor n/a    n/a n/a n 46





27 9 (4) n 47
HpcR Escherichia coli Repressor n/a      n/a n/a n 48, 49
BadR Rhodopseudomonas 
palustris 
Activator      Benzoate, 4-hydroxybenzoate
 
n/a n/a n 42
OhrR Xanthomonas 
campestris 
Repressor tert–butyl hydroperoxide, cumene 
hydroperoxide 
 
44 8 (17) n 50, 51 
OhrR Bacillus subtilis Repressor tert–butyl hydroperoxide, cumene 
hydroperoxide 
 




Repressor Cinnamic acid sugar esters 
 
     8 (0) n 55




21 5 (2) y 39, 56, 
19  
EmrR Escherichia coli Repressor Nalidixic acid, salicylate caronyl 
cyanide m-chlorophenylhydrazone 2, 
4–dinitrophenol, ethidium bromide 
 
42 9 (3) n 57, 58 
         Table cont
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Repressor uric acid, salicylate 
 





n/a 25d 5 (2) n 45, 64 
SlyA Enterobacter 
faecalis 
n/a n/a     n/a n/a y 65
HcaR Acinetobacter sp. 
Strain ADP1 





Repressor n/a 28 5 (5) y 67, 68 
CbaR Comamonas 
testosterone BR60 
Repressor  3-chlorobenzoate, protocatechuate
 
22 4 (6 or 9) n 69 
NhhD Rhodococcus 
rhodochrous J1 
Activator n/a     n/a n/a n 43
Hpr Bacillus subtilis Repressor n/a     n/a n/a n 70
ExpG Sinorhizobium 
meliloti 
Activator  n/a 21e 6 (3) n 71, 44 
a The smaller DNase I footprint size is indicated when footprint sizes are reported for both strands; footprint size is reported for 
sequences with lowest Kd; b Values reported involve cooperative binding to DNA site containing adjacent perfect and 
imperfect repeats; c Methidiumpropyl-EDTA-Fe(II) footprint;  d Footprint of a predicted high affinity site within a DNA 
sequence containing 5 predicted binding sites; e A conserved sequence found in three ExpG binding regions; f Number of base 
pairs for each half-site (number of base pairs between half sites in parentheses). This table was modified from Wilkinson et. al, 
2006 (86).  
                                                                                                                                                                                
                                                                                                                                                                                         Table cont. 
consisting of two independent domains: 1) a globular DNA binding domain displaying a 
winged helix motif and 2) a dimerization domain made up of the amino and carboxyl 
termini of the protein.  Extensive hydrophobic interactions appear to play a crucial role in 
subunit association.  Furthermore, dimerization requires that the equivalent region of 
each dimerization domain  intertwine to form the complete functional dimerization 
domain with extensive surface area buried at the interface. 
MarR 
 
 The first structure for the MarR family was the crystal structure of MarR that was 
determined to 2.3 Å resolution in the presence of its ligand, salicylate (19).   It revealed a 
dimer having a pyramidal shape with overall dimensions of 50 X 55 X 45 Å3 
(corresponding to the width, height, and depth relative to the orientation shown in Fig. 
4a).   The overall topological order of secondary structure in MarR is H1-H2-β1-H3-H4-
β2-W1-β3-H5-H6 with the winged helix DNA binding domain consisting of β1-H3-H4-
β2-W1-β3 (amino acids 55-100) and H1, H2, H5, and H6 making up the dimerization 
domains.  Furthermore, aside from being the first structure to represent this family of 
proteins, the MarR structure revealed the binding sites of its ligand, salicylate.  
 In order to get well diffracting crystals suitable for structure determination, an 
extremely high concentration of salicylate (250 mM) was used to co-crystallize MarR in 
the presence of the ligand.  Two salicylate binding sites per monomer were identified and 
called Sal-A and Sal-B (Fig. 4bc).  These sites are solvent exposed and are located on 
each side of the recognition helix (H3) at the surface of the molecule. Site Sal-A is the 
more conserved of the two sites with interactions taking place between residues from 
both the wing and the recognition helix.  Specifically, the guanidinium side chain of R86 
from the wing and the hydroxyl side chain of T72 from the recognition helix make 
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hydrogen bonds with the salicylate carboxylate and hydroxyl groups, respectively (Fig. 
4c).  Further stabilization of site Sal-A comes from the pyrrolidone ring positioned within 
3.5 Å of the salicylate ring.  Site Sal-B differs in that all interactions with salicylate are 
mediated only from the recognition helix.  The salicylate carboxylate makes a hydrogen 
bond to R77 while the backbone carbonyl of A70 makes a H-bond to the salicylate 
hydroxyl group (Fig. 4c).  Furthermore, similar to what is seen for Sal-A, the 
hydrophobic side chain from M74 sits just above the salicylate ring, thus stabilizing the 
ligand binding pocket via hydrophobic interactions.  The proximity of the ligand binding 
sites to the winged helix motif suggests a complete interlinkage of DNA and ligand 
binding regions. 
Although the co-crystal structure of MarR reveals sites Sal-A and Sal-B as 
binding sites of salicylate, one must be reminded that MarR has an apparent Kd for 
salicylate of 0.5-1 mM (56) and crystallization took place at a markedly high 
concentration of salicylate, 250 mM.  Furthermore, site Sal-A is involved in the crystal 
packing of symmetry-related molecules throughout the crystal lattice.  Thus, it is not 
possible to conclude whether these sites were an artifact of crystallization or true ligand 
binding sites of MarR.  However, if these sites are the physiological binding sites for 
salicylate, it appears rather straightforward that the mechanism for attenuation of DNA 
binding as a result of MarR binding salicylate is steric hindrance.  Binding two molecules 
of salicylate on each side of the recognition helix should inevitably prevent the 
recognition helix from recognizing and binding its cognate DNA sequence.  Furthermore, 
the confirmation in which MarR crystallized was not in a confirmation suitable for DNA 
binding, as the spacing of the recognition helices were not compatible with both 




 The second crystal structure for this family was that of MexR determined to 2.1 Å 
resolution (68).  MexR is a repressor of the MexAB-OprM operon that encodes a 
tripartite multidrug efflux system in Pseudomonas aeruginosa (67).  Furthermore, 
mutations in MexR result in the upregulation of the MexAB-OprM operon, thus 
conferring MDR, as evidenced by increased resistance to antimicrobials that include β-
lactams, tetracycline, chloramphenicol, novobiocin, trimethoprim, and sulfonamides (75-
88). 
 Repressor MexR was crystallized in the absence of an effector molecule (the 
physiological ligand for MexR has yet to be identified).  However, fortuitously, in the 
absence of an effector molecule, four independent observations of the dimer were made 
within the asymmetric unit, thus revealing the plasticity of these proteins as indicated by 
the varied conformations for each dimer observed.  This is markedly different than what 
was observed for MarR in which only a single monomer was observed in the asymmetric 
unit, with its dimer mate occurring on the crystallographic 2-fold, thus indicating 
relatively minimal flexibility, perhaps as a result of bound ligand.  One particular 
conformation found in dimer CD indicates a dimer in an “open” state that can be docked 
onto B-form DNA with a “reasonable” good fit, with the largest spacing between the two 
recognition helices from each DNA binding domain with a Cα-Cα distance of 29.2 Å 
(measured from Arg-73 to Arg-73΄, where prime denotes the other subunit).  The spacing 
between major grooves in linear B-form DNA is approximately 34 Å.  Another MexR 
conformation referred to as dimer AB was described as being in the “closed” 
conformation, unable to be docked onto DNA, with a short spacing between its 






























Figure 4.  The crystal structure of MarR and its salicylate binding sites. (A), Ribbon 
representation of the MarR dimer with each subunit represented by a different color. (B) 
The MarR monomer shown with its recognition helix (orange) and bound salicylate 
molecules (magenta) at sites Sal-A and Sal-B. (C) A stereo image of the salicylate 
binding sites Sal-A and Sal-B with salicylate molecules (magenta) and contact residues 








grooves on B-form DNA.  Using the DNA binding domains from one monomer to 
superpose dimer AB onto dimer CD (Fig. 5),  shows just how substantial the difference is 
in the “on” state (can bind DNA) compared to the “off” state (can not bind DNA).  
Interestingly, the structure of dimer AB shows the C-terminal tail (residues 140-147) of 
monomer C positioned between the lobes of the DNA binding domains of dimer AB 
resulting in a shortening of the distance between the recognition helices.  Thus, it has 
been suggested by Lim et al. that the uncharacterized ligand of MexR might mimic that 
which is seen in dimer AB, where a ligand binds to MexR between the DNA binding 
domains resulting in a neutralization of the electrostatic repulsions of these domains that 
usually exist to keep the lobes at optimal spacing to facilitate DNA binding.  Again, as in 
the MarR crystal structure, it is always possible that this observation is just an artifact of 
crystal packing and has no physiological relevance. 
OhrR 
 
 Very recently, the crystal structure of a MarR family repressor, OhrR, from 
Bacillus subtilis was solved in the absence and presence of DNA to resolutions of 2.5 and 
2.64 Å, respectively (54).  Upon exposure to oxidative stress, a conserved cysteine (C15) 
is oxidized to Cys-sulphenic acid which in turn causes a conformational change within 
the dimerization domain which is propagated to the DNA binding domain that ultimately 
results in the inability of OhrR to bind the ohrA operator, resulting in the derepression 
and upregulation of OhrA that encodes an organic hydroperoxide resistance protein 
(52,53).  In fact, a comparison of the unbound (i.e. reduced OhrR) and DNA bound 
structures of OhrR reveals a root mean square deviation (rmsd) of 1.5 Å to 1.7 Å, with 
differences primarily confined to the DNA binding domain.  Furthermore, in order for the 
unbound OhrR structure to assume the conformation of the DNA-bound form, the DNA 
 18
binding domain of one of the subunits must rotate ~25º relative to the other monomer and 
the wing must translocate ~16 Å (as measured from the Cα of E91΄) (Fig. 6). 
A 29 bp oligonucleotide containing the ohrA operator sequence was used to 
crystallize the OhrR-DNA complex.  The recognition helices (H4 and H4’) of the winged 
helix motif bind consecutive major grooves of the ohrA operator with the contacts 
primarily mediated by the N-termini of these helices (Fig. 7).  A total of 44 residues of 
the OhrR dimer were found to make 60 contacts with the DNA spanning over 22 
nucleotides.  Moreover, each subunit of the dimer exhibits almost identical 2-fold related 
interactions with the DNA.  The crystal structure revealed that the bound DNA is bent ~ 
10º globally while the major grooves are substantially widened (from 11 Å to 15.5 Å) and 
deepened (from 4.0 Å to 6.0 Å) as a result of the insertion of the recognition helix (H4).  
The wing from the winged helix DNA binding motif is inserted directly into the minor 
groove resulting in localized conformational change of the DNA (overtwisting of a DNA 
bp).  Wing residues R86, D92, and R94, which are highly conserved throughout the 
MarR family, perform the following functions in ohrA binding: R86 makes nonspecific 
phosphate backbone contacts, D92 helps coordinate the correct positioning of the 
guanidinium group of R94 through side chain electrostatic interactions, and R94 makes 
specific contacts with the nucleobase thymine.  Finally, DNA binding is further stabilized 
by several H-bonds to the phosphate groups along the phosphate backbone of the minor 
groove from residues on H2, and most strikingly, H1.  Thus, it appears that helix H1 not 













Figure 5. Conformational flexibility observed between MexR dimer AB and dimer 
CD.  Dimers AB (blue) and CD (red) were superposed onto one another relative to their 
DNA binding domain from one monomer. The recognition helices are shown in thicker 
rendering with cyan corresponding to dimer AB and brown corresponding to dimer CD. 
The distances between the recognition helices are measured from the Cα carbons of Arg-




















Figure 6.  Superposition of the reduced and DNA-bound OhrR dimers.  A 
superposition of the dimers of reduced OhrR (cyan) and DNA-bound OhrR (red) was 
done using  Cα carbons from one monomer.  The curved and straight orange arrows 
indicate the rotation angle and wing translocation of the nonsuperposed subunit of the 
DNA-bound OhrR relative to the reduced OhrR, respectively.  The bottom figure is 
















Figure 7.  The crystal structure of OhrR complexed with DNA.  OhrR is shown as a 
ribbon representation bound to the 29 bp ohrA operator depicted in stick format.  The 
recognition helices H4 and H4’ are embedded in the major groove of the DNA with the 


















THE CRYSTAL STRUCTURE OF HUCR: A MEMBER OF THE 
MARR FAMILY OF TRANSCRIPTIONAL REGULATORS 
 
 
Materials and Methods 
 
Protein Expression and Purification 
 
For expression of native HucR protein, E. coli BL21(DE3) pLysS was 
transformed with pSPW1 (41) in which the gene encoding HucR was cloned into the 
NdeI/EcoRI sites of the pET-5a expression vector.  A single colony was picked from a 
plate and incubated overnight in Terrific Broth (TB) containing 100 µg/ml ampicillin and 
34 µg/ml chloramphenicol.  A 1:100 dilution of this culture was made using fresh TB 
containing ampicillin and chloramphenicol and allowed to incubate at 37ºC with constant 
shaking (225 rpm) until the A600 reached 0.6 and isopropyl-ß-D-thiogalactopyranoside 
(IPTG) was added to a final concentration of 0.1 mM to induce HucR expression.  Upon 
induction, the temperature was reduced to 20 ºC and the cells were allowed to incubate 
for an additional 24 h with continuous shaking.  Cells were pelleted by centrifugation at 
5,500 X g for 10 min at 4 ºC followed by immediate freezing at -80 ºC.  Cells were lysed 
with Bugbuster (Novagen) followed by the addition of DNase I and protease inhibitors 
pepstatin and leupeptin.  Additionally, the cell lysate was sonicated twice in 5 min 
intervals to ensure complete cell lysis and to help solubilize HucR protein.  All 
subsequent purification procedures were carried out at 4 ºC. The crude lysate was 
centrifuged at 11,000 X g for 30 min with the resulting clarified lysate applied to a 10 ml 
Affi-Gel Blue Gel (Biorad) column equilibrated with Buffer A (10 mM Hepes, pH 7.0, 
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50 mM KCl, and 2 mM ß-Mercaptoethanol) in which HucR was allowed to bind.  The 
column was then washed with 10 column volumes of Buffer A followed by the elution of 
HucR from the column using 2 column volumes of Buffer A supplemented with 1 M 
KCl.  The eluted HucR was dialyzed in 2L of Buffer A overnight and subsequently 
applied to a 15 ml DEAE cellulose column equilibrated with Buffer A and washed with 
an additional column volume of Buffer A in which both the flow-through and wash 
volumes were collected.  HucR does not bind to this column.  This flow-through was 
immediately added to a 15 ml CM-cellulose column also equilibrated with Buffer A and 
washed with one column volume of Buffer A.  Again, HucR does not bind under these 
conditions and was collected in the flow-through volume.  The flow-through was then 
applied to a 12 ml hydroxylapatite column equilibrated with Buffer A and the column 
was washed with 5 column volumes of Buffer A.  HucR was eluted from this column in 
batch mode using 2 column volumes of Buffer A supplemented with 1M Potassium 
Phosphate.  As a final purification step, HucR was then applied to a Superdex 200 size 
exclusion column in which the purest fractions of HucR (as determined by SDS-PAGE) 
were pooled together and concentrated to 15 mg/mL and flash-frozen in liquid nitrogen 
for storage at -80 ºC (Fig. 8a).  Protein concentration was determined 
spectrophotometrically using A280 and a molar extinction coefficient for HucR (ε = 
13,940 M-1cm-1). 
 Selenomethionine-labeled (SeMet) HucR protein was expressed from pSPW1 
using E. coli BL21(DE3) pLysS.  An overnight culture grown in LB was used to make a 
1:100 dilution with fresh M9 media (6g Na2HPO4, 3g KH2PO4, 1g NH4Cl and 0.5 g 
NaCl) supplemented with 2 mM MgSO4, 0.1 mM CaCl2, and   4 g/L glycerol.  Cells were 
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grown until A600 reached 0.5 at which point 100 mg/L of amino acids Thr, Lys, Phe, and 
50 mg/L of Leu, Val, and Ile were added to the media to inhibit the methionine 
biosynthetic pathway.  Cells were grown for an additional 45 min to deplete residual 
cellular levels of L-methionine followed by a 0.2 mM IPTG induction, the addition of 50 
mg/L selenomethionine, and the reduction in temperature to 24 ºC.  Production of SeMet-
labeled HucR was allowed to proceed for 24 h before the cells were harvested.  
Purification of SeMet HucR was carried out as described above for the native HucR 
protein with the exception that Buffer A was supplemented with 10 mM ß-











Figure 8.  Purified native and SeMet HucR.  Purified protein was analyzed on an SDS-




Crystallization and Data Collection 
 
HucR crystals were grown by the hanging-drop vapor-diffusion method with 1:1 
mixtures of 12 mg/mL of protein and 22 % PEG 3350, 500 mM MgCl2, and 100 mM Bis-
Tris, pH 7.0 at 4 ºC.  Long rod-like hexagonal shaped crystals appeared after 4 days for 
the native HucR and after two weeks for the SeMet-labeled HucR (Fig. 9).  Native and 
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SeMet crystals belong to the hexagonal space groups P61 (a=b=45.0, c=284.6) and P6122 
(a=b=44.9, c=286.4), respectively, and were found to contain two and one molecule 
within their asymmetric unit, respectively. A third crystal form of space group P3121 
(a=b=77.3, c=266.4) was produced at room temperature in the same conditions 
supplemented with 1 mM Pb(NO3)2.  The room temperature crystal form, which has three 
dimers in the asymmetric unit, was merohedrally twinned with a twin fraction of 0.266 as 






Figure 9.  Crystals of native and selenomethionine-containing HucR. HucR crystals 
were obtained using the vapor diffusion method and photographed using a light 




Crystals were flash frozen in liquid nitrogen and diffraction data were collected 
with a MarCCD detector (165mm) at the protein crystallography beamline of the Center 
for Advanced Microstructures and Devices (CAMD, Louisiana State University) (Fig. 
10). All data processing and scaling was carried out with HKL2000 software (80).  An   
x-ray fluorescence scan was done to verify the presence of selenium in the SeMet crystals 
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and to determine the exact wavelengths that correspond to the peak and inflection 
wavelengths for selenium (Fig. 11).  Data was collected at three wavelengths (peak, 
inflection, and remote) for the SeMet HucR crystals to 2.6 Å resolution.  All data 
collection statistics are listed in Table 2. 
Structure Determination and Refinement 
 
Initial phases (Table 3) were obtained with multiple wavelength anomalous 
dispersion (MAD) phasing to 2.8 Å resolution with SeMet data sets.  Two of a possible 
four selenomethionine residues were apparent in a three-wavelength (peak, inflection, 
and remote) anomalous difference Patterson calculated with CNS (Fig. 12) After density 
modification which resulted in an overall figure of merit of 0.49, an electron density map 
was drawn revealing large solvent channels and continuous regions of electron density 
mostly resembling that of alpha helical secondary structure (Fig 13a). To more easily 
decipher the electron density, MapMan (81) was used to skeletonize the electron density 
(Fig 13bc) and a partial polyalanine model was built into the density using the program O 
(82).  Side chains were placed by using the selenomethionine sites and large tryptophan 
residues to indicate the correct register within the coding sequence.  Phase combination 
of model and experimental phases was performed to improve map quality until 
approximately two-thirds of the model was built. At this point 2Fo-Fc maps at 2.3 Å 
resolution were calculated.  
Once an Rfree value of 0.43 was obtained, the model derived from the SeMet data 
was positioned in the wild-type P61 unit cell for further refinement with non 
crystallographic symmetry (NCS) restraint weights of 400. The final 2.3 Å resolution 














Figure 10.  Native HucR diffraction image.  A diffraction image of the native HucR 






























Figure 11.  X-ray fluoresence scan for SeMet crystals.  The peak and inflection 
wavelengths for selenium in the SeMet crystal were found by doing a fluorescence scan 
at the PX beamline of CAMD and determined to be 12658 eV (0.9795 Å) and 12653 eV 




Table 2. Summary of data collection statistics. 
 
SeMet-MAD                                                         Native
Data set                                Peak           Inflection        Remote                   Native                        Native
Space group                        P6122                                                              P61                                           P3121
Unit cell            
a,b,c (Å)                         44.9, 44.9, 286.4                     45.0, 45.0, 284.6       77.3, 77.3, 266.4
α,β,γ (°) 90, 90, 120                                                          90, 90, 120                90, 90, 120
Wavelength (Å)                  0.9795           0.9798           0 .9500    1.380                        0.9505
Resolution range (Å)          50-2.65          50-2.65         50-2.65 50-2.30                    50-2.90
Unique reflections              5659               5714         5544                        14303                       21171
Completeness a  (%)     98.9 (99.8)     98.9 (100)     96.4 (99.6)               98.8 (95.8)               98.6 (99.7)
Redundancy a 13.1 (9.2)       10.0 (9.3)   5.8 (7.7)                   4.4 (3.8)                   3.5 (3.5)
I/σ a  13.9(4.2)     15.9 (5.0)   9.3 (4.0)                  12.1 (8.1)                  8.9 (2.7
Rsym b (%)                           13.3 (49.0)  11.0 (47.3)  12.4 (47.6)               7.5 (20.4)                 12.6 (45.5)
aHighest resolution shell in parentheses




Table 3.  MAD phasing and structure refinement statistics. 
 




Phasing    
     Resolution range (Å) 500-2.8   
     Figure of merit 




     Phasing power 




Refinement    
     Resolution range (Å)  500-2.3 50-2.9 
     Rcryst/Rfree ab(%)  23.5/29.0 22.1/30.4 
     No. of nonhydrogen atoms 





     rms from ideal geometry 
          Bonds (Å) 







     Average B-factor (Å2) 







     Ramachandran plot 
          Res. in most favored regions (%) 
          Res. in add. allowed regions (%) 
          Residues in gen. allowed regions (%) 













aR = Σ||Fo| - |Fc|| / Σ|Fo|, where Fo and Fc are the observed and calculated structure factor 
amplitudes. 





Figure 12.   Patterson map.  The z = 0.5 Harker section of a 3-wavelength anomalous 






Figure 13.  Electron density from initial phases.   (A) Electron density map contoured 
to 1σ after density modification (solvent flipping) in CNS.  (B) The skeletonized electron 
density from panel A was made using mapman.  (C) The final Cα trace of HucR (yellow), 




terminus (residues 1-7), the last two residues on the carboxyl terminus, the wing residues 
121-127, and loop residues 27-35 were not visible in the electron density map.  In 
addition, amino acid residues 25, 36, 88, and 120 have no convincing electron density for 
side-chain placement. Final refinement statistics are shown in Table 3 and a 
representative 2Fo – Fc electron density map contoured at 1σ is depicted in Figure 14.  All 
figures were prepared using PYMOL (83), GRASP (84), or O. 
The dimer was positioned in the P3121 unit cell with molecular replacement as 
implemented in CNS. Six dimers were identified in the asymmetric unit giving a 
Matthews coefficient (Vm) of 1.93, within the typical ranges of 1.62-3.53.  Refinement 
was done in CNS keeping each monomer restrained by NCS weights of 500. The 





Figure 14.  Representative 2Fo – Fc electron density map.  A stereo image of a 
representative 2Fo – Fc electron density map contoured to 1σ showing the HucR 





The atomic coordinates and structure factors have been deposited in the Protein 
Data Bank under the PDB ID 2FBK. 
Results and Discussion 
 
Overall Structure of HucR 
 
The crystal structure of the HucR dimer was determined to 2.3 Å and refined to a 
final Rcryst of 23.5% and Rfree of 29.0%. HucR has a “saddle-like” shape with overall 
dimensions of 62 Å wide, 42 Å tall and 37 Å deep relative to the orientation shown in Fig 
15a.   The protein is largely α-helical (55% α-helix, 5% β-strand) with the topology α1-
α2- α3-β1-α4-α5-β2-β3-α6-α7 (Fig. 15b). The first helix, α1, has no counterpart in any 
other MarR family members for which structures have been described. Helices from the 
amino and carboxyl termini (α2, α6, and α7) form the dimerization domain, while the 
DNA-binding domain is composed of α3, β1, α4, α5, β2, and β3 (Fig. 15b).  As predicted, 
 32
the structure reveals that HucR adopts a similar winged-helix fold as that seen in the 
structures for MarR, MexR, and OhrR (19,68,54). Consistent with that of other winged-
helix proteins (16), the electrostatic surface potentials of HucR surrounding the 
recognition helix (α5) and the wing regions are electropositive, and are likely to interact 















Figure 15.  Overall structure of HucR.  (A) The HucR dimer is shown in a ribbon 
drawing with one monomer colored by spectrum from N to C while the other monomer is 
depicted in gray.  (B)  The HucR monomer is shown with each secondary structural 
element colored and labeled. The DNA binding domain is encased in a black box (α3, β1, 
α4, α5, β2, and β3). The dimerization domain consists of α2, α6, and α7. (C,D) The 
electrostatic potential surface map of HucR with positively and negatively charged 
regions shown in blue and red, respectively. Figure C is shown in the same orientation 
relative to A above, while D is rotated 90° around the x-axis relative to C with the bottom 













The DNA Binding Domain 
 
The DNA binding domain (residues 65 – 133) corresponds to a contiguous stretch 
of polypeptide flanked by regions that form the dimerization domain and is comprised of 
α3, β1, α4, α5, β2, and β3 (Fig. 15b). The winged-helix motif characteristic of the MarR 
family is an adaptation of the classical helix-turn-helix DNA binding motif and in HucR 
corresponds to short α-helices, α4 and α5, that pack at approximately 110°,  followed by 
two anti-parallel β-strands (β2 and β3) that form a β-hairpin referred to as the “wing.” 
Helix α3 appears to serve as a scaffold-like structure for this domain as it mediates the 
majority of interactions within its own domain and those with the dimerization domain as 
well. The crystal structure reveals that the DNA binding domains of HucR are completely 
independent of one another, in contrast to what is observed for MarR in which a salt 
bridge links the two domains together. 
The 17 residue β-hairpin “wings” of HucR jut out from the globular portion of the 
DNA binding domains to provide an exceptionally electropositive surface (Fig. 15c,d):  
six of the 17 amino acids are arginines (118, 119, 123, 125, 126, and 130).  Previous 
biochemical evidence has shown that R118A HucR binds DNA with an affinity reduced 
6-fold compared to that for wild type HucR (63). Moreover, the R118A mutant had no 
effect on sequence specificity of DNA binding, thus it is tempting to speculate that the 
wing is important for maintaining non-specific HucR/DNA interactions similar to what is 
observed in other canonical winged helix proteins (16).  
Most winged helix proteins make sequence specific contacts to their respective 
DNA targets via the recognition helix that immediately precedes the wing motif (16).  In 
the crystal structure of HucR, helix α5 (residues 101-113) is designated the recognition 
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helix, and is unusual in the fact that its amino terminus is a very short 3-residue 3-10 
helix which turns into a typical 8-residue right-handed α-helix.  The electrostatic potential 
map shows that HucR’s recognition helix is electropositive on both sides, a common 
feature for many winged-helix DNA binding proteins (Fig. 15c,d).  In the crystal 
structure, the recognition helix is anchored to the central scaffold helix of the DNA 
binding domain (α3) via a salt bridge between Arg-106 and Asp-73 and side chain 
hydrogen bonding between Arg-109 and Asn-68.  In addition, Lys-113 makes a hydrogen 
bond to the main chain carbonyl group of Gly-66, located on a turn between helices α2 
and α3.  Furthermore, this Lys-113/Gly-66 interaction is functionally identical to side 
chain- main chain H-bonds in MarR (Lys-81/Asp-37) and MexR (Arg-78/Asp-34) and 
OhrR (Gln-81/Asn-37).  Such an interaction may be necessary to anchor the C-terminal 
end of the recognition helix in a position suitable for DNA binding.  
A structure-based sequence alignment of HucR, MarR, MexR, and OhrR is 
presented in Figure 16.  Hydrophobic residues conserved throughout the DNA binding 
domain appear to be important in stabilization of the overall fold of the DNA binding 
domain. In fact, the DNA binding domain has about twice as many invariant and/or 
highly conserved residues compared to the dimerization domain (Fig. 16), while it 
represents just one third of the protein. The bulk of the conserved amino acids are located 
in the hydrophobic core and include  Leu-67, -74, -75, -78, -87,  -92, -110, -115 -132 and 
Ile-107, -116,-130 (Fig. 17).  Another invariant residue from the MarR family of 
transcriptional regulators is Thr-133 which is located at the proximal end of the wing 
between β3 and helix α6.  This residue appears to clamp the wing in place by making two 
hydrogen bonding interactions:  its side chain hydroxyl group makes an H-bond (2.7 Å) 
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with the backbone carbonyl of Gly-114 and the main chain nitrogen participates in an H-
bond (2.9 Å) with the backbone carbonyl of Leu-115.  The length of the wing is further 
stabilized by typical β-sheet interactions and an additional salt bridge between Arg-131 
and Glu-117.  There is insufficient electron density in the map to model the residues that 
comprise the distal wing (121-127), most likely as a consequence of a high degree of 
flexibility in this region. Such mobility is common in winged helix proteins, especially 







Figure 16.  Structure based sequence alignment between HucR, MarR, MexR, and 
OhrR.  Secondary structural elements and residue numbering corresponds to that of 
HucR.  Residues shown in red font have no interpretable electron density in the structure 
of HucR and were not used in the superpositioning of the structures.  Regions of amino 
acid conservation corresponding to invariant and similar are shaded in cyan and yellow, 






Figure 17.  Hydrophobic interactions of the DNA binding domain.  The DNA binding 
domain of HucR forms a compact globular domain with a hydrophobic core; many of the 
core residues are highly conserved within the MarR family, including Leu-67, -74, -75,    
-78, -87,  -92, -110, -115 -132 and Ile-107, -116,-130. 
 
 
The Dimerization Domain 
 
Helices α2, α6, α7, α2´, α6΄, and α7΄ (where prime denotes the other subunit) form 
the intertwined helical bundle that constitutes the dimerization domain.  Helices α2 and 
α2΄ are oriented in an anti-parallel fashion to form the scaffold of the dimerization 
interface, while helices α6 and α7 straddle helix α2΄ and α6΄ and α7΄ straddle α2. As a 
consequence of interdigitation of the helices, approximately 6300 Å2 of surface area is 
buried at the dimerization interface. At the center of this packing located along the two-
fold rotation axis of the dimer is a π-stacking interaction between the imidazole rings of 
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His-51 and His-51΄ in which the rings are parallel and separated by a distance of 3.6 Å 
(Fig. 14).  Helices α2 and α2΄ also interact through hydrophobic interactions that include 
Leu-54/Leu-44΄ and Leu-50/Leu-47΄, and there two well-ordered pockets of water 
molecules located on either side of the stacked His-51/His-51΄ rings.  The C-terminal 
helix α7 forms a coiled coil leucine zipper-like structure with extensive hydrophobic 
interactions with α2΄, while α6 and α2΄ make only limited hydrophobic contacts.  
Additional interactions that contribute to dimer stabilization are the intermolecular salt 
bridges Arg-172/Glu-162΄ (α7/α7΄) and Arg-17/Glu-167΄ (α1/α7΄).  An intramolecular 
salt bridge between Arg-153 and Glu-57 stabilizes an interaction between the amino and 
carboxyl terminal helices that flank the DNA binding domain.  
 Interestingly, the crystal structure of HucR and the structure-based alignment 
(Fig. 16) reveal two conserved residues that might play a critical role in dimerization for 
members of the MarR family.  Residues Leu-166, which is strictly conserved in the MarR 
superfamily, and Leu-166΄ of HucR make contact at the two-fold rotation axis.  They, 
along with other hydrophobic residues, collectively participate in the formation of the 
compact core of the dimerization domain, thus stabilizing helices α7, α7΄, α2, and α2΄ at 
this site.  The MarR, MexR, and OhrR equivalents (Leu-139, Leu-131, and Leu-132, 
respectively) of Leu-166 in those structures participate in similar van der Waals 
interactions.  Leu-158 from HucR, also conserved in MexR and MarR, serves to anchor a 
turn region located between helices α6 and α7 to the carboxyl terminal helix α7΄ of the 
opposing monomer.  Residues corresponding to Leu-158 in both MarR and MexR (Leu-
127 and Leu-123, respectively) perform a similar structural role in those proteins and are 
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likely to have a similar function in all MarR family members given that this residue is 
highly conserved throughout the superfamily. 
As referred to above, near the midpoint of the 40 Å long α2 and α2΄ helices that 
provide the framework for the dimerization domain, the imidazole rings of  His-51 and 
His-51΄ are stacked and separated by a distance of 3.6 Å (Figs. 14 and 18) At pH 7.0, the 
pH at which the crystals were obtained, the imidazoles would be expected to be 
deprotonated and thus such an interaction is permissible. However, this configuration of 
His-side chains suggests that the dimer interface can serve as a pH sensor, and that a 
transient drop in pH could lead to a conformational change induced by the repulsion of 
like charges.  Conformational changes at the dimer interface of MarR family members 
result in repositioning of the DNA binding domains. Thus DNA binding is abrogated if 
the domains are repositioned such that spacing between the recognition helices of 
winged-helix motifs is not compatible with the distance between the major groves of the 
cognate operator. In the MexR structure, determined in the absence of ligand or DNA, 
four independent dimers were observed and the relative orientations of the monomers 
within each dimer differ as a result of deviations at the dimerization interfaces, and 
structural heterogeneity in the monomer itself (68).  The structure of the reduced form of 
the oxidative stress sensor OhrR in the absence and presence of DNA similarly revealed 
differences at the dimer interface (54). Furthermore, the authors propose that oxidation of 
the conserved Cys, located at the amino terminus of the α-helix of OhrR that corresponds 













Figure 18.  Imidazole ring stacking at the HucR dimerization interface.  (A) A global 
view of the HucR dimer shown as a Cα trace with helices α2 and α2΄ shown as a ribbon 
drawing (gold) and His-51 and His-51΄ imidazoles shown in stick format (green and 





 In addition to the 2.3 Å structure of HucR, a second crystal form (space group 
P3121) was solved in the absence of ligand to 2.9 Å with three dimers found in the 
asymmetric unit.  Superpositioning of all three dimers from the second crystal form with 
the original P61 dimer using 314 Cα carbons revealed that there is very little flexibility 
between each of the observed HucR dimers as indicated by a similar positioning of the 
DNA binding lobes from each monomer relative to the other (Fig. 19). In fact the 
variation in r.m.s. deviation between all four dimers was between 0.6 Å and 1.4 Å.  This 
is in stark contrast to what is seen in the crystal structure of MexR in which there are 
significant differences in the positioning of the DNA binding domains, specifically for 
dimer AB compared to dimer CD (Fig. 5)   Furthermore, the authors suggest that it is this 
flexibility that is likely responsible for determining whether MexR can or cannot bind its 
cognate DNA as a direct result of the positioning of the two DNA binding domains 
relative to one another (68). Additionally, the observation that MarR was unable to 
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crystallize in the absence of its ligand supports the possibility that it too has inherent 
conformational flexibility.  Thus, the HucR dimer appears to lack the conformational 
flexibility that is observed in MexR and MarR and likely stays in a more fixed 






Figure 19.  Superposition of HucR dimers.   The three dimers from the P3121 space 
group crystal form and the one dimer from the P61 crystal form were superposed using 
314 Cα carbons to illustrate the lack of conformational heterogeneity between the four 
HucR dimers. The Cα traces for the dimers are  shown (the  P61 dimer is green). 
 
 41
The crystal structure of HucR also reveals that the lobes of the DNA binding 
domains are positioned with a spacing compatible with DNA binding.  Superposition of 
the HucR dimer on the structure of the OhrR DNA-bound dimer puts the recognition 
helices from each subunit directly on top of one another, suggesting that no major 
reorientation of the domain interface is necessary to position the DNA binding domains 
to make contacts in the major grooves of its operator, hucO (Fig. 20a,b). Thus, due to the 
lack of conformational flexibility as noted above, it is our belief that HucR remains fixed 
in a “DNA ready” confirmation in which the lobes of the DNA binding domains are in a 
position ready to bind DNA.  However, a localized conformational change is needed in 
residues 99-104 consisting of the loop between helices α4 and α5 (i.e. the turn of the 
HTH motif) and the N-terminal end of α5 (the recognition helix) in order to become fully 
compatable with DNA binding, as that defined by the OhrR-DNA structure (fig 20a,b).  
Furthermore, the N-termini of the recognition helices adopt a 3-10 helix secondary 
structure at the position of the largest degree of steric clashing between HucR and DNA 
(most notably Pro-101 and Ser-102), it is possible that DNA binding facilitates the 
reorientation of this region of the recognition helix to allow for proper major groove 
binding interactions.  To further support this hypothesis, figure 21 shows a distribution of 
the thermal B-factors for HucR in which relatively high values (as compared to the other 
regions of HucR) are found at the N-termini of the recognition helices. High B-factors 
generally indicate increased thermal motion or regions of disorder as a consequence of 
increased motion.  Thus in contrast to what is observed for OhrR in the absence of  DNA, 
the  dimer interface  of  HucR in  the absence of DNA  is  compatible with  DNA  






Figure 20.  Superposition of the HucR dimer on the OhrR-DNA bound dimer and 
DNA.  (A) Superposition of HucR (red) on the OhrR-DNA bound structure (blue) with 
heavy black circles indicating similar positioning of the recognition helices and heavy 
green circles representing the N-terminal regions of the recognition helices of HucR that 
require minor localized conformational changes to facilitate DNA binding.  (B)  The 
DNA binding domain of HucR (red, recognition helix yellow) modeled onto DNA 
according to the superposition in (A). Positions at which HucR clashes with the DNA are 

















carbons in HucR is shown so that B-factors are color coded from highest values to low
values (i.e. red→ orange→ yellow→ green→ cyan → blue).  Heavy black circles located 
at the N-terminal regions of the recognition helices correspond to regions that have high 
















stal structure of HucR has given new insight into the MarR family of 
transcriptional regulators as well as emphasized reoccurring themes throughout this 
family.  The overall structure of HucR is largely alpha helical having structural topology 
very similar to the structures of other MarR family members, with the exception of an 
additional α-helix at the amino terminus.  The function of this helix is unknown and 
awaits future investigation, however, the crystal structure suggests that it might function 
to further stabilize the primary dimerization helix, α2, as demonstrated by several 
hydrophobic interactions.  The HucR dimer has a “saddle-like” shape in which the 
subunits are extensively intertwined which results in approximately 6300 Å  of surface 
are buried at the dimerization interface with most of these contacts mediated primarily by 
van der Waals interactions. 
HucR has two domains: 1) a dimerization domain comprised of α-helices from 
both the amino and carboxyl termini and 2) a globular DNA binding domain composed of 
residues encoded within the interior of the polypeptide.  As predicted, HucR adopts a 
similar winged helix motif as seen for other MarR homologs for which structures have 
been described.  Furthermore, the electrostatic surface potentials of HucR indicate that 
the regions around the recognition helices and the wing are highly electropositive, and are 









A second crystal form (P3121) of HucR was solved containing three dimers in the 
asymmetric unit.  Comparison of these three dimers with the original dimer of the first 
crystal form (P61) reveals that there is very little conformational heterogeneity among the 
four dimers: the  r.m.s. deviation range is from  0.6 Å to 1.4 Å.  This is in contrast to 
what was described for the structure of MexR, in which significant variations in the 
MexR dimers were observed.  Furthermore, a superposition of the HucR dimer with the 
structure of the DNA-bound OhrR, reveals that HucR is in a “DNA ready” confirmation 
in which the lobes of the DNA binding domains are in a position ready to bind DNA with 
the exception of some localized conformational changes needed at the amino termini of 
the recognition helices.  Interestingly, a comparison of the OhrR DNA-bound structure 
with the nonbound OhrR reveals that significant reorientation of the DNA binding 
domains occurs upon DNA binding. Since HucR is in a DNA ready conformation in the 
absence of DNA, we suggest that HucR might remain fixed in this state at all times, even 
in the absence of DNA or ligand.  The fact that four independent observations of the 
HucR dimer show that HucR maintains this state is further evidence that supports that 
HucR remains fixed in a DNA ready confirmation.  If this is true, how does HucR lose its 
ability to bind DNA, as demonstrated by the presence of uric acid.  One possibility is that 
the ligand binds to a region of the winged helix DNA binding motif and actively blocks 
DNA interactions via steric hindrance, similar to what is believed to occur with MarR 
and its ligand, salicylate.  A second possibility, is that urate binding induces a 
conformational change resulting in a displacement of the DNA binding domain in a 
conformation not compatible with DNA binding.  The fact that HucR crystals 
immediately crack when soaked with uric acid indicate that significant conformational 
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change likely occurs upon ligand binding.  The site for which uric acid binds has yet to be 
determined.  Interestingly, a third possibility is that the stacked imidazole rings from His-
51 and His-51΄ might act as a pH sensor and should there be a transient drop in pH so that 
the rings become protonated, the resulting repulsion of like charges could lead to a 
localized conformational change that would be propagated out to the lobes of the DNA 
binding domains placing them in a position not compatible with DNA binding. This 
might be advantageous to the cell if uric acid solubility is compromised during transient 
drops in pH which would result in an upregulation of cellular uricase levels to ensure uric 
acid is degraded before it precipitates within the cell.  Interestingly, a substitution of 
phenylalanine for histidine at this position would eliminate the possibility of protonation 
while still allow the pi-stacking interactions to take place, thus providing a nice system to 
test this hypothesis of pH-mediated abrogation of DNA binding. 
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